GW Pharmaceuticals Plc (GWPH)

135.75
3.51 2.52
NASDAQ : Health Technology
Prev Close 139.26
Open 140.55
Day Low/High 133.00 / 142.99
52 Wk Low/High 90.14 / 179.65
Volume 660.49K
Avg Volume 472.30K
Exchange NASDAQ
Shares Outstanding 30.45M
Market Cap 4.18B
EPS -10.60
P/E Ratio N/A
Div & Yield N.A. (N.A)
Week Ahead: It Gets Quieter as Wall Street Looks Down Road for Fed Meeting

Week Ahead: It Gets Quieter as Wall Street Looks Down Road for Fed Meeting

Wall Street is looking at a quieter coming week with just a trickle of economic data to analyze before the Federal Reserve meeting on Dec. 13-14.

GW Pharmaceuticals Stock Poised to Hit New Heights After Marijuana's Election Day Boost

GW Pharmaceuticals Stock Poised to Hit New Heights After Marijuana's Election Day Boost

The British-based pharmaceutical company offers one of the best plays for investing in the growing legal marijuana industry.

Even in a Trump Presidency, Marijuana Is a Good Investment

Even in a Trump Presidency, Marijuana Is a Good Investment

The U.S. president elect has said in the past that he favors the legalization of marijuana, and he is unlikely to change his stance significantly.

Don't Let Post-Election Market Volatility Scare You Into Ruining Your Retirement

Don't Let Post-Election Market Volatility Scare You Into Ruining Your Retirement

Volatility in the stock markets should not be feared by investors, because any large gains or losses are often reversed after the panic or euphoria subsides.

Nasdaq Cannabis Stocks Rally After Recreational and Medical Use Passes

Nasdaq Cannabis Stocks Rally After Recreational and Medical Use Passes

Cannabis stocks listed on the Nasdaq continued to rally after voters ended prohibition and approved the recreational use of marijuana in California, Massachusetts, Maine and Nevada.

Nasdaq Cannabis Stocks Spike in Volume Ahead of Election for Recreational and Medical Use

Nasdaq Cannabis Stocks Spike in Volume Ahead of Election for Recreational and Medical Use

The volume of cannabis stocks listed on the Nasdaq have spiked ahead of the election as voters decide tomorrow on recreational and medical use of marijuana.

'Mad Money' Lightning Round: J.C. Penney Is 'A Lot Better,' Jim Cramer Says

'Mad Money' Lightning Round: J.C. Penney Is 'A Lot Better,' Jim Cramer Says

Jim Cramer says JCP is better, but 'just OK,' and investors should be careful with CEMP.

Jim Cramer's 'Mad Money' Recap: It's Chicago Versus Cleveland -- Stocks, That Is

Jim Cramer's 'Mad Money' Recap: It's Chicago Versus Cleveland -- Stocks, That Is

Jim Cramer says the market can have many winners.

Stocks Ready to Benefit From Rising Marijuana Legalization, Usage

Stocks Ready to Benefit From Rising Marijuana Legalization, Usage

Legalization of marijuana for medical reasons or otherwise is already on the ballot in Arkansas, California, North Dakota and several other states.

Pot Is on the Ballot in Election 2016, but Investors Should Proceed With Caution

Pot Is on the Ballot in Election 2016, but Investors Should Proceed With Caution

Marijuana is on the ballot in several states this election cycle, and its approval could be a boon for those in the business -- though obstacles remain.

Here's Why These 3 Cheap Marijuana Stocks May Quadruple in Price

Here's Why These 3 Cheap Marijuana Stocks May Quadruple in Price

Shares of these cannabis companies are ready for huge growth if November is a successful month for legalization.

GW Pharmaceuticals Stock Can Make Even More Gains -- Here's Why

GW Pharmaceuticals Stock Can Make Even More Gains -- Here's Why

The company's share price has increased 1,500% since 2013.

Rev's Forum: Stock Pickers Have Some Opportunities

Rev's Forum: Stock Pickers Have Some Opportunities

But the buyers are still unable to produce sustained momentum.

GW Pharmaceuticals Is Taking Off as the Cannabis Industry Grows

GW Pharmaceuticals Is Taking Off as the Cannabis Industry Grows

Analysts are predicting that the legal pot market could reach $6.7 billion in sales this year.

Jim Cramer -- Gilead Needs to Make an Acquisition

Jim Cramer -- Gilead Needs to Make an Acquisition

Investors shouldn't give up on Gilead's Hep. C drug, Cramer says.

Cramer: How Do You Play This Answer to the Opiate Epidemic?

Cramer: How Do You Play This Answer to the Opiate Epidemic?

GW Pharma could be the answer to an opiate addiction that isn't understood.

Jim Cramer's Top Takeaways: GW Pharmaceuticals, Apple, Align Technology

Jim Cramer's Top Takeaways: GW Pharmaceuticals, Apple, Align Technology

Cramer continues to back Apple and says Align Technology is a stock to buy now.

Jim Cramer's 'Mad Money' Recap: Why Tonight's Debate Doesn't Really Matter

Jim Cramer's 'Mad Money' Recap: Why Tonight's Debate Doesn't Really Matter

Investors hate uncertainty, Cramer says, but uncertainty creates bargains.

Stocks Fall Ahead of Clinton-Trump Debate, Crude Rallies

Stocks Fall Ahead of Clinton-Trump Debate, Crude Rallies

Stocks hold near session lows by mid-afternoon Monday as Wall Street grows restless ahead of the first presidential debate.

GW Pharmaceuticals (GWPH) Stock Soars on Positive Trial Results, Piper Jaffray Bullish

GW Pharmaceuticals (GWPH) Stock Soars on Positive Trial Results, Piper Jaffray Bullish

GW Pharmaceuticals (GWPH) said on Monday its seizure drug epidiolex had positive results in a late-stage clinical trial.

Stephen King's Maximum Oversold (by Midweek)

And we'll get FOMC and BoJ then.

'Mad Money' Lightning Round: Abbvie Is a Great Long-Term Position

'Mad Money' Lightning Round: Abbvie Is a Great Long-Term Position

Cramer is sticking with International Paper and likes Advanced Micro Devices.

Jim Cramer's 'Mad Money' Recap: Why You Shouldn't Be Jumping In and Out of Stocks

Jim Cramer's 'Mad Money' Recap: Why You Shouldn't Be Jumping In and Out of Stocks

This is not the time to sell in a panic, Cramer says.

4 Companies Likely to Benefit From Widening Legalization of Marijuana

4 Companies Likely to Benefit From Widening Legalization of Marijuana

The marijuana market is heating up as marijuana usage for medical and recreational purposes gains legitimacy.

GW Pharmaceuticals (GWPH) Closed Higher on Takeover Speculation

GW Pharmaceuticals (GWPH) Closed Higher on Takeover Speculation

GW Pharmaceuticals (GWPH) reportedly hired Morgan Stanley after it was approached by several companies about a possible takeover.

TheStreet Quant Rating: D (Sell)